7.86
price up icon6.22%   0.46
after-market Handel nachbörslich: 7.86
loading

Upstream Bio Inc Aktie (UPB) Neueste Nachrichten

pulisher
09:56 AM

Price to book forward of Upstream Bio, Inc. – NASDAQ:UPB - TradingView

09:56 AM
pulisher
Jul 06, 2026

UPBUpstream Bio Inc Dividends - Finviz

Jul 06, 2026
pulisher
Jul 02, 2026

Here's Why We're Watching Upstream Bio's (NASDAQ:UPB) Cash Burn Situation - Moomoo

Jul 02, 2026
pulisher
Jun 29, 2026

Enterprise value to EBIT forward of Upstream Bio, Inc. – NASDAQ:UPB - TradingView

Jun 29, 2026
pulisher
Jun 28, 2026

UpStream Bio(UPB) Stock Options Chain | Quotes & News - Moomoo

Jun 28, 2026
pulisher
Jun 28, 2026

Why Did UPB Stock Plunge 40% Today? - Stocktwits

Jun 28, 2026
pulisher
Jun 26, 2026

UPB News | UPSTREAM BIO INC (NASDAQ:UPB) - ChartMill

Jun 26, 2026
pulisher
Jun 26, 2026

Upstream Bio, Inc. (UPB) reports Q1 loss, beats revenue estimates - MSN

Jun 26, 2026
pulisher
Jun 26, 2026

Upstream Bio, Inc. Actuals & Estimates (NASDAQ:UPB) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Upstream Bio, Inc. Actuals & Estimates (BOATS:UPB) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

UPB Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Is Upstream Bio, Inc. (UPB) a Rising Biotech Opportunity After New Analyst Coverage? - Insider Monkey

Jun 25, 2026
pulisher
Jun 24, 2026

Enterprise value to EBITDA forward of Upstream Bio, Inc. – NASDAQ:UPB - TradingView

Jun 24, 2026
pulisher
Jun 23, 2026

JPMorgan Cuts Upstream Bio Stock Target to Eight Dollars - sekbernews.id

Jun 23, 2026
pulisher
Jun 23, 2026

Is Upstream Bio, Inc. (UPB) the Best Low Priced Stocks to Get Rich in 2026? - Yahoo Finance

Jun 23, 2026
pulisher
Jun 22, 2026

Upstream Bio Inc (UPB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 22, 2026
pulisher
Jun 20, 2026

UPB Technical Analysis & Stock Price Forecast - Intellectia AI

Jun 20, 2026
pulisher
Jun 19, 2026

Upstream Bio Inc (UPB) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 19, 2026
pulisher
Jun 18, 2026

Upstream Bio Inc (UPB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

Upstream Bio Inc (UPB) Institutional Confidence - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Top Executive Makes Strategic Move With Upstream Bio Stock - TipRanks

Jun 17, 2026
pulisher
Jun 17, 2026

Upstream Bio Inc (UPB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Upstream Bio Inc (UPB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Upstream Bio Inc (UPB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

Upstream Bio Inc (UPB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 16, 2026
pulisher
Jun 16, 2026

Upstream Bio Inc (UPB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 16, 2026
pulisher
Jun 14, 2026

Upstream Bio presents positive Phase 2 trial data for verekitug By Investing.com - Investing.com Nigeria

Jun 14, 2026
pulisher
Jun 14, 2026

Upstream Bio presents positive Phase 2 trial data for verekitug - Investing.com

Jun 14, 2026
pulisher
Jun 14, 2026

Upstream Bio, Inc. unveils Phase 2 VIBRANT trial data showing majority of verekitug recipients achieve key improvements - Traders Union

Jun 14, 2026
pulisher
Jun 14, 2026

Upstream Bio Reports Positive Phase 2 Results for Verekitug in Chronic Rhinosinusitis with Nasal Polyps, Achieving Clinically Meaningful Improvements in Key Symptoms - Quiver Quantitative

Jun 14, 2026
pulisher
Jun 14, 2026

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements ... - Caledonian Record

Jun 14, 2026
pulisher
Jun 14, 2026

Upstream Bio Presents New Responder Analyses Demonstrating - GlobeNewswire

Jun 14, 2026
pulisher
Jun 13, 2026

Upstream Bio Inc. (UPB) Falls 4.39% as Shares Test Key Support LevelGamma Exposure - newsline.com

Jun 13, 2026
pulisher
Jun 13, 2026

UPB Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Progress ContinuesEstimate Accuracy - newsline.com

Jun 13, 2026
pulisher
Jun 12, 2026

Upstream Bio Cut to Neutral From Overweight by JP Morgan - Moomoo

Jun 12, 2026
pulisher
Jun 12, 2026

Upstream Bio lead drug pivotal trial plan follows strong phase 2 data - MSN

Jun 12, 2026
pulisher
Jun 12, 2026

JPMorgan Downgrades Upstream Bio to Neutral From Overweight, Cuts Price Target to $8 From $35 - marketscreener.com

Jun 12, 2026
pulisher
Jun 12, 2026

JPMorgan downgrades Upstream Bio stock rating on execution risks By Investing.com - Investing.com Australia

Jun 12, 2026
pulisher
Jun 12, 2026

J.P. Morgan Downgrades UpStream Bio(UPB.US) to Hold Rating, Announces Target Price $8 - Moomoo

Jun 12, 2026
pulisher
Jun 11, 2026

Upstream Bio Shareholders Elect Directors, Ratify 2026 Auditor - The Globe and Mail

Jun 11, 2026
pulisher
Jun 10, 2026

Upstream Bio, Inc. leadership to share strategy at major Goldman Sachs event - Traders Union

Jun 10, 2026
pulisher
Jun 10, 2026

Upstream Bio (UPB) Declines 3.6%: Support at $6.13 in Focus After Selling PressureParabolic SAR - dars.gov.et

Jun 10, 2026
pulisher
Jun 08, 2026

Upstream Bio (UPB) Declines 4% as Shares Approach Key Support at $6.42Thematic ETF Flow - newsline.com

Jun 08, 2026
pulisher
Jun 08, 2026

Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026 - markets.businessinsider.com

Jun 08, 2026
pulisher
Jun 08, 2026

Upstream Bio to present verekitug trial data at medical congress By Investing.com - Investing.com Australia

Jun 08, 2026
$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
Kapitalisierung:     |  Volumen (24h):